Beyond Air has submitted a supplement application for its second-generation LungFit PH 2 device for treating PPHN.

A trial of Insmed’s TPIP suggests daily doses of the inhaled dry powder are well tolerated and may improve blood flow in ...

The first participant has been dosed in a Phase 1 trial testing F230 for the treatment of pulmonary arterial hypertension.

Turning 30 is something columnist Anna Jeter never expected to do because of a childhood PH diagnosis. She grapples with the ...

A study of HB-1614 suggests it may improve exercise capacity in adults with pulmonary hypertension associated with ...

Adding more lines of treatment may reduce the risk of rehospitalization among adults with PAH who are taking only one ...

Transplanting gut microbes from healthy rats into a rat model of PAH led to a reduction in disease severity, suggesting a ...